A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia.
Clinical trial NCT04806503 · TERMINATED
Trial details
- NCT number
- NCT04806503
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2022-07-27
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.